KBC Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $58K | Hold |
1,844
| – | – | ﹤0.01% | 1534 |
|
2025
Q1 | $61K | Hold |
1,844
| – | – | ﹤0.01% | 1727 |
|
2024
Q4 | $63K | Buy |
1,844
+819
| +80% | +$28K | ﹤0.01% | 1768 |
|
2024
Q3 | $41K | Hold |
1,025
| – | – | ﹤0.01% | 1776 |
|
2024
Q2 | $31K | Hold |
1,025
| – | – | ﹤0.01% | 1811 |
|
2024
Q1 | $34K | Hold |
1,025
| – | – | ﹤0.01% | 1728 |
|
2023
Q4 | $33K | Sell |
1,025
-248
| -19% | -$7.98K | ﹤0.01% | 1765 |
|
2023
Q3 | $42K | Sell |
1,273
-1,188
| -48% | -$39.2K | ﹤0.01% | 1585 |
|
2023
Q2 | $87K | Hold |
2,461
| – | – | ﹤0.01% | 1234 |
|
2023
Q1 | $80K | Hold |
2,461
| – | – | ﹤0.01% | 1273 |
|
2022
Q4 | $136K | Hold |
2,461
| – | – | ﹤0.01% | 1089 |
|
2022
Q3 | $109K | Buy |
2,461
+458
| +23% | +$20.3K | ﹤0.01% | 1154 |
|
2022
Q2 | $98K | Buy |
+2,003
| New | +$98K | ﹤0.01% | 1227 |
|